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The authors of the above-mentioned paper
noticed some errors subsequent to publication
and would like to make the following
corrections:
On page 1199, under the heading Dual
Energy X-ray Absorptiometry (Table 1), the
sentence ‘‘The gold standard for quantitative
assessment of bone mineral status in adults is
dual energy X-ray absorptiometry (DXA),
performed at the lumbar spine (L1–L4) and hip
(total hip or femoral neck).’’ should read ‘‘The
gold standard for quantitative assessment of
bone mineral status in adults is dual energy
X-ray absorptiometry (DXA), performed at the
lumbar spine (L1–L4) and hip (total hip and
femoral neck).’’ Here, the word ‘or’ in the
second brackets is replaced by ‘and’.
In the original supplementary material, the
references cited in Supplementary Tables 1 and
2 were not updated during editing and as such
do not correlate with the reference list in the
published manuscript. These have been
updated in the electronic supplementary
material associated with this erratum.
The online version of the original article can be found
under doi:10.1007/s12325-014-0174-0.
Electronic supplementary material The online
version of this article (doi:10.1007/s12325-015-0196-2)
contains supplementary material, which is available to
authorized users.
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Furthermore, in Case 2 of the original
supplementary material, Supplementary Table
A was omitted. This has been provided in the
electronic supplementary material associated
with this erratum.
Finally, ‘‘(Supplement 1)’’ on page 1199 in
the section Case Reports and ‘‘(Supplement)’’ on
page 1206 in the section Enzyme Replacement
Therapy should both refer to ‘‘(Supplementary
material 2)’’.
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